Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
Type
Physical Book
Publisher
Language
Inglés
Pages
228
Format
Paperback
Dimensions
23.4 x 15.6 x 1.3 cm
Weight
0.34 kg.
ISBN13
9789811575884

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Tuli, Hardeep Singh (Author) · Springer · Paperback

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models - Tuli, Hardeep Singh

New Book

£ 114.85

  • Condition: New
Origin: U.S.A. (Import costs included in the price)
It will be shipped from our warehouse between Friday, July 26 and Friday, August 02.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models"

This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways for the treatment of cancer and to develop personalized medicine. Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews